1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-02-01 Sage Accounts Production Advanced 2023 - FRS102_2023 3,496 560 4,056 2,376 747 3,123 933 1,120 xbrli:pure xbrli:shares iso4217:GBP 09386579 2023-02-01 2024-01-31 09386579 2024-01-31 09386579 2023-01-31 09386579 2022-02-01 2023-01-31 09386579 2023-01-31 09386579 2022-01-31 09386579 bus:OrdinaryShareClass1 2023-02-01 2024-01-31 09386579 bus:Director1 2023-02-01 2024-01-31 09386579 core:WithinOneYear 2024-01-31 09386579 core:WithinOneYear 2023-01-31 09386579 core:ShareCapital 2024-01-31 09386579 core:ShareCapital 2023-01-31 09386579 core:RetainedEarningsAccumulatedLosses 2024-01-31 09386579 core:RetainedEarningsAccumulatedLosses 2023-01-31 09386579 core:BetweenOneFiveYears 2024-01-31 09386579 core:BetweenOneFiveYears 2023-01-31 09386579 bus:Director1 2023-01-31 09386579 bus:Director1 2024-01-31 09386579 bus:Director1 2022-01-31 09386579 bus:Director1 2023-01-31 09386579 bus:Director1 2022-02-01 2023-01-31 09386579 bus:SmallEntities 2023-02-01 2024-01-31 09386579 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 09386579 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 09386579 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 09386579 bus:FullAccounts 2023-02-01 2024-01-31 09386579 bus:OrdinaryShareClass1 2024-01-31 09386579 bus:OrdinaryShareClass1 2023-01-31 09386579 core:OfficeEquipment 2023-01-31 09386579 core:OfficeEquipment 2023-02-01 2024-01-31 09386579 core:OfficeEquipment 2024-01-31
COMPANY REGISTRATION NUMBER: 09386579
The London Hip And Knee Clinic Ltd
Filleted Unaudited Financial Statements
For the year ended
31 January 2024
The London Hip And Knee Clinic Ltd
Financial Statements
Year ended 31 January 2024
Contents
Pages
Statement of financial position
1 to 2
Notes to the financial statements
3 to 6
The London Hip And Knee Clinic Ltd
Statement of Financial Position
31 January 2024
2024
2023
Note
£
£
£
Fixed assets
Tangible assets
5
933
1,120
Current assets
Debtors
6
203,682
175,197
Cash at bank and in hand
352,343
330,255
---------
---------
556,025
505,452
Creditors: amounts falling due within one year
7
68,983
62,389
---------
---------
Net current assets
487,042
443,063
---------
---------
Total assets less current liabilities
487,975
444,183
---------
---------
Net assets
487,975
444,183
---------
---------
Capital and reserves
Called up share capital
8
1
1
Profit and loss account
487,974
444,182
---------
---------
Shareholders funds
487,975
444,183
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
The London Hip And Knee Clinic Ltd
Statement of Financial Position (continued)
31 January 2024
These financial statements were approved by the board of directors and authorised for issue on 21 October 2024 , and are signed on behalf of the board by:
Mr Bhupinder S Mann
Director
Company registration number: 09386579
The London Hip And Knee Clinic Ltd
Notes to the Financial Statements
Year ended 31 January 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Mornington House, 20 Penington Road, Beaconsfield, England, HP9 1ET.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in UK sterling, which is the functional currency of the entity. Monetary amounts in these financial statements are rounded to the nearest UK pound.
Trade receivables
Trade receivable do not carry any interest and are stated at their original invoice value as reduced by appropriate allowances for estimated irrecoverable amounts.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax. Revenue from services provided is recognised when the significant risks and rewards have transferred to the buyer, usually on the provision of services.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income. In this case, tax is recognised in other comprehensive income. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
33.33% Straight line
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Tangible assets
Equipment
Total
£
£
Cost
At 1 February 2023
3,496
3,496
Additions
560
560
-------
-------
At 31 January 2024
4,056
4,056
-------
-------
Depreciation
At 1 February 2023
2,376
2,376
Charge for the year
747
747
-------
-------
At 31 January 2024
3,123
3,123
-------
-------
Carrying amount
At 31 January 2024
933
933
-------
-------
At 31 January 2023
1,120
1,120
-------
-------
6. Debtors
2024
2023
£
£
Trade debtors
27,673
37,190
Other debtors
176,009
138,007
---------
---------
203,682
175,197
---------
---------
7. Creditors: amounts falling due within one year
2024
2023
£
£
Social security and other taxes
61,791
54,086
Other creditors
7,192
8,303
--------
--------
68,983
62,389
--------
--------
8. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
1
1
1
1
----
----
----
----
9. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
2024
2023
£
£
Not later than 1 year
14,357
14,357
Later than 1 year and not later than 5 years
23,929
38,286
--------
--------
38,286
52,643
--------
--------
10. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr Bhupinder S Mann
136,785
191,273
( 153,313)
174,745
---------
---------
---------
---------
2023
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr Bhupinder S Mann
97,562
153,626
( 114,403)
136,785
--------
---------
---------
---------
An amount of £3,402 (2023 - £2,320) based on the official rate of interest on beneficial loan of 2.00% & 2.25% (2023 - 2.00%) was charged on the loan to the director.
11. Related party transactions
The company entered into the following related party transactions during the year:
Nature of Relationship Transaction Type 2024 2023
£ £
Director Balance due to/(from) (174,745) (136,785)
An amount of £3,402 (2023 - £2,320) based on the official rate of interest on beneficial loan of 2.00% & 2.25% (2023 - 2.00%) was charged on the loan to the director.